Prelude Capital Management’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

Prelude Capital Management’s Portfolio CORV Stock Details CORV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-108,112	Closed	-$216K	–	2399
2019 Q3	$216K	Hold	108,112	–	–	0.01%	742
2019 Q2	$234K	Sell	108,112 -14,705	-12%	-$37.6K	0.01%	686
2019 Q1	$388K	Buy	122,817 +54,552	+80%	+$176K	0.02%	548
2018 Q4	$170K	Buy	+68,265	New	+$227K	0.01%	780
2015 Q3	–	Sell	-3,000	Closed	-$28K	–	1916
2015 Q2	$28K	Buy	+3,000	New	+$28K	﹤0.01%	1295
2015 Q1	–	Sell	-600	Closed	-$6K	–	2305
2014 Q4	$6K	Buy	+600	New	+$5.05K	﹤0.01%	1833

Other funds holding CORV

Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Summer Road West Palm Beach, Florida $161M AUM 27.24% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

AIP

ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $203M AUM 34.78% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Prelude Capital Management's CORV Position: Q4 2019 in Review

Prelude Capital Management sold out of Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) in Q4 2019, closing a stake of 108,112 shares — an estimated $216K sold.

Prelude Capital Management first reported a position in CORV in Q4 2014 and held it in 6 quarters. The position peaked at $388K in Q1 2019. 31 funds tracked by Wall St. Rank hold CORV as of Q4 2019.

Prelude Capital Management reported no remaining Correvio Pharma Corp. Ordinary Shares (Canada) position as of Q4 2019 after selling out during the quarter.
Prelude Capital Management sold 108,112 Correvio Pharma Corp. Ordinary Shares (Canada) shares in Q4 2019, an estimated $216K.
Prelude Capital Management first reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) in Q4 2014 and held it in 6 quarters.
Prelude Capital Management's Correvio Pharma Corp. Ordinary Shares (Canada) position peaked at $388K in Q1 2019.
31 funds tracked by Wall St. Rank held Correvio Pharma Corp. Ordinary Shares (Canada) as of Q4 2019.

Based on Prelude Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.